Literature DB >> 21855806

The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo.

Stefano Campaner1, Fabio Spreafico, Thomas Burgold, Mirko Doni, Umberto Rosato, Bruno Amati, Giuseppe Testa.   

Abstract

p53 is the central regulator of cell fate following genotoxic stress and oncogene activation. Its activity is controlled by several posttranslational modifications. Originally defined as a critical layer of p53 regulation in human cell lines, p53 lysine methylation by Set7/9 (also called Setd7) was proposed to fulfill a similar function in vivo in the mouse, promoting p53 acetylation, stabilization, and activation upon DNA damage (Kurash et al., 2008). We tested the physiological relevance of this circuit in an independent Set7/9 knockout mouse strain. Deletion of Set7/9 had no effect on p53-dependent cell-cycle arrest or apoptosis following sublethal or lethal DNA damage induced by radiation or genotoxic agents. Set7/9 was also dispensable for p53 acetylation following irradiation. c-myc oncogene-induced apoptosis was also independent of Set7/9, and analysis of p53 target genes showed that Set7/9 is not required for the p53-dependent gene expression program. Our data indicate that Set7/9 is dispensable for p53 function in the mouse.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855806     DOI: 10.1016/j.molcel.2011.08.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  46 in total

1.  Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells.

Authors:  Rajan Gogna; Esha Madan; Bernhard Keppler; Uttam Pati
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

3.  Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.

Authors:  Tewfik Hamidi; Anup Kumar Singh; Nicolas Veland; Vidyasiri Vemulapalli; Jianji Chen; Swanand Hardikar; Jianqiang Bao; Christopher J Fry; Vicky Yang; Kimberly A Lee; Ailan Guo; Cheryl H Arrowsmith; Mark T Bedford; Taiping Chen
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

Review 4.  An unexpected journey: lysine methylation across the proteome.

Authors:  Kaitlyn E Moore; Or Gozani
Journal:  Biochim Biophys Acta       Date:  2014-02-20

Review 5.  Transcriptional regulation by the Set7 lysine methyltransferase.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

Review 6.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

7.  Functions of SETD7 during development, homeostasis and cancer.

Authors:  Natalia Soshnikova
Journal:  Stem Cell Investig       Date:  2019-09-02

Review 8.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

Review 9.  Emerging roles of lysine methylation on non-histone proteins.

Authors:  Xi Zhang; Yaling Huang; Xiaobing Shi
Journal:  Cell Mol Life Sci       Date:  2015-07-31       Impact factor: 9.261

10.  SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer.

Authors:  Yongchun Song; Jianli Zhang; Tao Tian; Xiao Fu; Wenjuan Wang; Suoni Li; Tingting Shi; Aili Suo; Zhiping Ruan; Hui Guo; Yu Yao
Journal:  Tumour Biol       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.